Article Information
History
- March 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Betty M. Tijms1,†,
- Johan Gobom2,3,
- Lianne Reus1,
- Iris Jansen1,
- Shengjun Hong18,
- Valerija Dobricic18,
- Fabian Kilpert18,
- Mara ten Kate1,
- Frederik Barkhof4,5,
- Magda Tsolaki6,
- Frans RJ Verhey7,
- Julius Popp8,9,
- Pablo Martinez-Lage Alvarez10,
- Rik Vandenberghe11,12,
- Alberto Lleó13,
- José Luís Molinuevo14,15,
- Sebastiaan Engelborghs16,17,
- Lars Bertram18,
- Simon Lovestone19,
- Johannes Streffer16,20,
- Stephanie Vos7,
- Isabelle Bos1,7,
- ADNI*,
- Kaj Blennow2,3,
- Philip Scheltens1,
- Charlotte E. Teunissen21,
- Henrik Zetterberg2,3,22,23 and
- Pieter Jelle Visser1,7,24
- 1Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands
- 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 3Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- 4Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands
- 5Institutes of Neurology & Healthcare Engineering, UCL London, London, United Kingdom
- 61st Department of Neurology, AHEPA University Hospital, Makedonia, Thessaloniki, Greece
- 7Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands
- 8University Hospital Lausanne, Lausanne, Switzerland
- 9Geriatric Psychiatry, Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland
- 10Fundación CITA-Alzhéimer Fundazioa, San Sebastian, Spain
- 11Neurology Service, University Hospitals Leuven, Leuven, Belgium
- 12Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
- 13IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona Spain
- 14Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain
- 15Alzheimer’s Disease Unit and Other Cognitive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain
- 16Institute Born-Bunge, Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Belgium
- 17Department of Neurology, UZ Brussel and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium
- 18Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Cardiogenetics, University of Lübeck, Lübeck, Germany
- 19University of Oxford, Oxford, United Kingdom (currently at Jansen R&D)
- 20UCB Biopharma SPRL, Brain-l’Alleud, Belgium
- 21Neurochemistry laboratory, Department of Clinical Chemistry, Amsterdam University Medical Centers (AUMC), Amsterdam Neuroscience, Netherlands
- 22Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom
- 23UK Dementia Research Institute at UCL, London, United Kingdom
- 24Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm Sweden
- ↵†Please address correspondence to: B.M. Tijms, PhD., Alzheimer Center and Department of Neurology, Amsterdam University Medical Centers, Amsterdam, Neuroscience, Amsterdam PO Box 7057, 1007 MB, Amsterdam, The Netherlands., Telephone: +31 204448524, Email: b.tijms{at}amsterdamumc.nl
Posted March 27, 2020.
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
